The government will start booster vaccination on January 12, 2022.
REPUBLIKA.CO.ID, JAKARTA – The government will start vaccination booster on January 12, 2022. For non-government or independent vaccination programs, payment is applied. However, the government has not set the tariff for vaccination booster the.
“There is no official fee that has been set by the government,” said Spokesperson for Covid-19 Vaccination, Ministry of Health of the Republic of Indonesia, Siti Nadia Tarmizi in Jakarta, Tuesday (4/1).
In the price fixing process, continued Nadia, it must involve various parties such as the Financial and Development Supervisory Agency (BPKP). The type and dose of vaccine to be given is still waiting for confirmation and recommendations from ITAGI and research studies booster which is running and in accordance with the approval of a circulation permit or Emergency Use Authorization (EUA) from BPOM.
Vaccination booster prioritized for health workers, the elderly, PBI participants, and comorbid groups with immunocompromised. Vaccinations for non-government or independent programs can be financed by individuals or business entities and are carried out at state-owned hospitals, private hospitals, or private clinics.
However, the government continues to provide free vaccinations in government programs for the elderly, BPJS Kesehatan participants in the PBI group, and other vulnerable groups.
Previously, the Minister of Health of the Republic of Indonesia, Budi Gunadi Sadikin, said that vaccination booster will be given to groups of adults aged over 18 years according to recommendations from WHO. Vaccination booster it will also only be given to districts/cities that have met the criteria for 70 percent of the first injection and 60 percent for the second injection.
“Until now there are 244 regencies/cities that have met these criteria,” he said.
Furthermore, he said, vaccination booster it will be given over a period of 6 months after the second dose. The Ministry of Health has identified around 21 million targets that have fallen into this category as of January.
“And kind of booster We will determine later, some are homologous or the same type, some are heterologous with different vaccine types. Yes, hopefully it will be decided soon on the 10th (January) after the recommendations from ITAGI and BPOM come out,” he said.